Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christian Drosten and Marcel Müller.
Christian Drosten
Connection Strength
6.466
Marcel Müller
  1. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis. 2014 Dec; 20(12):2093-5.
    View in: PubMed
    Score: 0.604
  2. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio. 2012 Dec 11; 3(6).
    View in: PubMed
    Score: 0.527
  3. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun. 2021 06 21; 12(1):3818.
    View in: PubMed
    Score: 0.238
  4. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe. 2021 Jul; 2(7):e311-e319.
    View in: PubMed
    Score: 0.235
  5. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe. 2021 May; 2(5):e210-e218.
    View in: PubMed
    Score: 0.233
  6. The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species. PLoS Pathog. 2018 09; 14(9):e1007296.
    View in: PubMed
    Score: 0.197
  7. Link of a ubiquitous human coronavirus to dromedary camels. Proc Natl Acad Sci U S A. 2016 08 30; 113(35):9864-9.
    View in: PubMed
    Score: 0.170
  8. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015 Jun; 15(6):629.
    View in: PubMed
    Score: 0.156
  9. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015 May; 15(5):559-64.
    View in: PubMed
    Score: 0.155
  10. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014 Aug 28; 371(9):828-35.
    View in: PubMed
    Score: 0.148
  11. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis. 2014 Aug; 20(8):1319-22.
    View in: PubMed
    Score: 0.148
  12. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis. 2014 Jun; 20(6):1012-5.
    View in: PubMed
    Score: 0.146
  13. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis. 2014 Apr; 20(4):552-9.
    View in: PubMed
    Score: 0.144
  14. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014 Dec 19; 194:175-83.
    View in: PubMed
    Score: 0.144
  15. Replicative Capacity of MERS Coronavirus in Livestock Cell Lines. Emerg Infect Dis. 2014 Feb; 20(2):276-9.
    View in: PubMed
    Score: 0.143
  16. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol J. 2013 Dec 23; 10:359.
    View in: PubMed
    Score: 0.142
  17. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis. 2014 Jan 15; 209(2):243-6.
    View in: PubMed
    Score: 0.140
  18. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol. 2013 Nov; 87(22):12489-95.
    View in: PubMed
    Score: 0.139
  19. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013 Sep; 13(9):745-51.
    View in: PubMed
    Score: 0.137
  20. Amplification of emerging viruses in a bat colony. Emerg Infect Dis. 2011 Mar; 17(3):449-56.
    View in: PubMed
    Score: 0.116
  21. Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane protein. Virol J. 2010 Jan 15; 7:6.
    View in: PubMed
    Score: 0.108
  22. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis. 2009 Sep; 15(9):1377-84.
    View in: PubMed
    Score: 0.105
  23. Plaque assay for human coronavirus NL63 using human colon carcinoma cells. Virol J. 2008 Nov 12; 5:138.
    View in: PubMed
    Score: 0.099
  24. Coronavirus antibodies in African bat species. Emerg Infect Dis. 2007 Sep; 13(9):1367-70.
    View in: PubMed
    Score: 0.091
  25. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021 10 08; 374(6564):eabh1823.
    View in: PubMed
    Score: 0.061
  26. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct; 27(10):1520.e7-1520.e10.
    View in: PubMed
    Score: 0.059
  27. Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany. Nat Commun. 2021 04 09; 12(1):2117.
    View in: PubMed
    Score: 0.059
  28. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Front Immunol. 2021; 12:629185.
    View in: PubMed
    Score: 0.058
  29. Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures. J Clin Virol. 2021 05; 138:104796.
    View in: PubMed
    Score: 0.058
  30. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2020; 11:628971.
    View in: PubMed
    Score: 0.058
  31. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020 11; 587(7833):270-274.
    View in: PubMed
    Score: 0.056
  32. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020 09; 585(7826):588-590.
    View in: PubMed
    Score: 0.056
  33. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. Emerg Infect Dis. 2020 Jul; 26(7):1478-1488.
    View in: PubMed
    Score: 0.056
  34. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 05 21; 64(6).
    View in: PubMed
    Score: 0.055
  35. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature. 2020 06; 582(7813):561-565.
    View in: PubMed
    Score: 0.055
  36. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020 05; 581(7809):465-469.
    View in: PubMed
    Score: 0.055
  37. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 04 16; 181(2):271-280.e8.
    View in: PubMed
    Score: 0.054
  38. Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence. Elife. 2020 02 03; 9.
    View in: PubMed
    Score: 0.054
  39. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2020; 9(1):155-168.
    View in: PubMed
    Score: 0.054
  40. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat Commun. 2019 12 18; 10(1):5770.
    View in: PubMed
    Score: 0.054
  41. Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels: a prospective genomic study. Lancet Planet Health. 2019 12; 3(12):e521-e528.
    View in: PubMed
    Score: 0.054
  42. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2019 10; 25(10):1878-1883.
    View in: PubMed
    Score: 0.053
  43. Shared Common Ancestry of Rodent Alphacoronaviruses Sampled Globally. Viruses. 2019 01 30; 11(2).
    View in: PubMed
    Score: 0.050
  44. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization. J Virol. 2019 01 15; 93(2).
    View in: PubMed
    Score: 0.050
  45. Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017. Emerg Microbes Infect. 2018 Nov 28; 7(1):195.
    View in: PubMed
    Score: 0.050
  46. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Antivir Ther. 2018; 23(7):617-622.
    View in: PubMed
    Score: 0.048
  47. Transcriptome profile of lung dendritic cells after in vitro porcine reproductive and respiratory syndrome virus (PRRSV) infection. PLoS One. 2017; 12(11):e0187735.
    View in: PubMed
    Score: 0.046
  48. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity. Diagn Microbiol Infect Dis. 2017 Oct; 89(2):106-111.
    View in: PubMed
    Score: 0.045
  49. No Serologic Evidence of Middle East Respiratory Syndrome Coronavirus Infection Among Camel Farmers Exposed to Highly Seropositive Camel Herds: A Household Linked Study, Kenya, 2013. Am J Trop Med Hyg. 2017 Jun; 96(6):1318-1324.
    View in: PubMed
    Score: 0.045
  50. Time Course of MERS-CoV Infection and Immunity in Dromedary Camels. Emerg Infect Dis. 2016 12; 22(12):2171-2173.
    View in: PubMed
    Score: 0.044
  51. Serologic Evaluation of MERS Screening Strategy for Healthcare Personnel During a Hospital-Associated Outbreak. Infect Control Hosp Epidemiol. 2017 02; 38(2):234-238.
    View in: PubMed
    Score: 0.043
  52. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci U S A. 2016 08 30; 113(35):E5192-201.
    View in: PubMed
    Score: 0.042
  53. MERS-CoV Antibodies in Humans, Africa, 2013-2014. Emerg Infect Dis. 2016 06; 22(6):1086-9.
    View in: PubMed
    Score: 0.042
  54. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection. Clin Infect Dis. 2016 Feb 15; 62(4):477-483.
    View in: PubMed
    Score: 0.040
  55. Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014. Emerg Infect Dis. 2015 Aug; 21(8):1422-5.
    View in: PubMed
    Score: 0.040
  56. Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia. J Clin Microbiol. 2015 Sep; 53(9):2951-5.
    View in: PubMed
    Score: 0.039
  57. Serologic assessment of possibility for MERS-CoV infection in equids. Emerg Infect Dis. 2015 Jan; 21(1):181-2.
    View in: PubMed
    Score: 0.038
  58. Inhibition of proprotein convertases abrogates processing of the middle eastern respiratory syndrome coronavirus spike protein in infected cells but does not reduce viral infectivity. J Infect Dis. 2015 Mar 15; 211(6):889-97.
    View in: PubMed
    Score: 0.037
  59. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog. 2014 May; 10(5):e1004166.
    View in: PubMed
    Score: 0.036
  60. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013 Oct; 13(10):859-66.
    View in: PubMed
    Score: 0.034
  61. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013 Mar 14; 495(7440):251-4.
    View in: PubMed
    Score: 0.034
  62. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio. 2013 Feb 19; 4(1):e00611-12.
    View in: PubMed
    Score: 0.033
  63. Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread. J Gen Virol. 2012 Dec; 93(Pt 12):2601-2605.
    View in: PubMed
    Score: 0.032
  64. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res. 2012 Apr; 165(1):112-7.
    View in: PubMed
    Score: 0.031
  65. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 2011 Oct; 7(10):e1002331.
    View in: PubMed
    Score: 0.030
  66. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol. 2011 Dec; 85(24):13363-72.
    View in: PubMed
    Score: 0.030
  67. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011 May; 85(9):4122-34.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.